Multiple mechanisms of crizotinib resistance were identified in lung cancer patients including new secondary ALK mutations and activation of receptor tyrosine kinases.
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!